Zacks Value Trader Highlights: Dream Finders Homes, Tenet Healthcare, El Pollo Loco, The Greenbrier Companies and Pediatrix Medical

For Immediate ReleaseChicago, IL – November 25, 2024 – Zacks Value Trader is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2374108/5-cheap-strong-buy-stocks-values-or-traps5 Cheap Strong Buy Stocks: Values or Traps?Welcome to Episode #389 of the Value Investor Podcast.(0:30) - Screening Criteria For Top Value Stocks(6:10) - Top Stocks To Keep On Your Watchlist Right Now(25:30) - Episode Roundup: DFH, THC, LOCO, GBX, MD            Podcast@Zacks.com Value Investor portfolio, shares some of her top value investing tips and stock picks.With the end of the year approaching, and the stock market rally still intact, it’s time to look at some cheap Zacks #1 Rank (Strong Buy) stocks. This is the highest Zacks Rank and makes up just 5% of all the Zacks Ranked stocks.But just because they are cheap, on a price-to-earnings or price-to-sales basis, and have the Strong Buy recommendation, which usually means the analysts are raising earnings estimates, doesn’t mean that they are a true value.Values or Traps: How to Tell?Remember, just because a stock has a low P/E or P/S ratio, doesn’t necessarily mean it’s a true value stock. The key is to look at the earnings growth that is expected for next year.Is the company expected to grow earnings year-over-year?Because while value investors want to buy cheap stocks, they also want companies that are growing earnings.Screening for Cheap Strong Buy StocksZacks has a premium screen called “Undervalued Zacks #1 Stocks” that looks for, obviously, Zacks #1 (Strong Buy) stocks, but also adds a cheapness component.It must have a price-to-earnings (P/E) ratio under 20 and a price-to-sales (P/S) ratio under 1. A P/S ratio under 1.0 indicates an investor is getting the sales at a discount.Also, to avoid microcaps, the screen looks for stocks that are over $5 and have average trading volume over 100,000 per day.This screen returned 15 stocks.5 Cheap Strong Buy Stocks: Values or Traps?1. Dream Finders Homes, Inc. DFHDream Finders Homes is a Jacksonville, FL homebuilder with a market cap of $2.6 billion. It builds in 9 states including Florida and Texas.Shares of Dream Finders Homes are down 14.2% year-to-date. It’s cheap with a forward P/E of just 8.1. Dream Finders Homes also has a P/S ratio of just 0.6. Earnings are expected to rise 20% in 2024.It was recently announced that Dream Finders Homes was to join the S&P Small Cap 600 index.Is Dream Finders Homes a value or a trap heading into 2025?2. Tenet Healthcare Corp. THCTenet Healthcare is a large cap company in ambulatory surgery centers, surgical hospitals, outpatient facilities and other medical services.Earnings are looking good in 2024. Tenet is expected to grow 2024 earnings by 63%. The analysts are bullish. 1 earnings estimate has been revised higher for 2024 and 2025 in the last week.Shares of Tenet have soared 95% year-to-date but remain cheap. It has a forward P/E of just 13.5.Is Tenet Healthcare a value or trap heading into 2025?3. El Pollo Loco Holdings, Inc. LOCOEl Pollo Loco operates 495 restaurants in 7 states featuring fire grilled, fresh citrus marinated chicken. Celebrating its 50th anniversary, El Pollo Loco intends to expand to El Paso, Boise, Kansas City and Seattle-Tacoma in 2025.Shares of El Pollo Loco have rallied 37% year-to-date but it is still cheap, with a forward P/E of just 15.8. Earnings of this small cap restaurant company are expected to rise 16.9% in 2024.Is El Pollo Loco a value or a trap heading into 2025?4. The Greenbrier Companies, Inc. GBXGreenbrier manufactures and leases freight railcars and offers freight services. It is a small cap company with a market cap of $2 billion.An analyst is bullish. 1 earnings estimate has been revised higher in the last 30 days for both 2024 and 2025. Greenbrier’s earnings are expected to rise 4.8% in 2024.Shares of Greenbrier are up 49% year-to-date and are trading near 5-year highs. Yet it’s still cheap with a forward P/E of just 12.4.Is Greenbrier a value or a trap heading into 2025?5. Pediatrix Medical Group, Inc. MDPediatrix Medical Group is a national provider of prenatal, neonatal, and pediatric services. It has a market cap of $1.3 billion.Analysts are bullish. 1 earnings estimate has been revised higher on Pediatrix Medical Group for 2024 in just the last week. Earnings are expected to be up 7.1% this year.Shares of Pediatrix Medical Group have jumped 58% year-to-date. But it remains a cheap stock with a forward P/E of just 10.8.Is Pediatrix Medical Group a value or a trap heading into 2025?What Else Should You Know about Values Versus Traps?Tune into this week’s podcast to find out.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.About ZacksZacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch/Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.com/performancePast performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis Report Pediatrix Medical Group, Inc. (MD): Free Stock Analysis Report Greenbrier Companies, Inc. (The) (GBX): Free Stock Analysis Report El Pollo Loco Holdings, Inc. (LOCO): Free Stock Analysis Report Dream Finders Homes, Inc. (DFH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks